XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets (Additional Information) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Aug. 22, 2022
Feb. 17, 2022
Goodwill [Line Items]          
Goodwill $ 27,946   $ 26,713    
Amortization expense 3,805 $ 0      
Future amortization expense, thereafter 68,400        
Goodwill, impairment losses 0        
Collaboration agreement          
Goodwill [Line Items]          
Amortization expense 3,800        
In-process research and development | Collaboration agreement          
Goodwill [Line Items]          
Amortization expense 0        
La Jolla Pharmaceutical Company          
Goodwill [Line Items]          
Goodwill       $ 16,453  
Future amortization expense, remainder of 2023 11,600        
Future amortization expense, 2024 15,400        
Future amortization expense, 2025 15,400        
Future amortization expense, 2026 15,400        
Future amortization expense, 2027 15,400        
Intangible assets pertain to product rights and developed technologies 151,000     $ 151,000  
Entasis Therapeutics Holdings Inc          
Goodwill [Line Items]          
Goodwill         $ 11,493
Intangible assets pertain to product rights and developed technologies 106,700       $ 106,700
Entasis Therapeutics Holdings Inc | Collaboration agreement          
Goodwill [Line Items]          
Intangible assets pertain to product rights and developed technologies 35,400        
Entasis Therapeutics Holdings Inc | In-process research and development          
Goodwill [Line Items]          
Intangible assets pertain to product rights and developed technologies $ 71,300